Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jacotot

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
La Revue De Medecine Interne|January 1, 1996
[Homocysteine: relations to ischemic cardiovascular diseases]A Piolot, F Nadler, N Parez, et al.
Biochimica Et Biophysica Acta|August 28, 1990
Fluidity changes and chemical composition of lipoproteins in type IIa hyperlipoproteinemiaC Dachet, C Motta, D Neufcour, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 12, 1975
[The composition of dietary lipids and the blood coagulation time in the rat]B Jacotot, H Rosenstein, M Claire, et al.
The American Journal of Medicine|June 6, 1994
Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study GroupJ D Banga, B Jacotot, P Pfister, et al.
British Journal of Clinical Pharmacology|September 1, 1994
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study GroupB Jacotot, J D Banga, P Pfister, et al.
Pathologie-Biologie|June 29, 2001
Effect of an alpha-blocker (Nicergoline) and of a beta-blocker (Acebutolol) on the in vitro biosynthesis of vascular extracellular matrixM Moczar, A M Robert, B Jacotot, et al.
Atherosclerosis|October 1, 1986
Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemiaM F Baudet, O Esteva, C Dachet, et al.
Clinical Physiology and Biochemistry|January 1, 1986
Dietary modifications of low-density lipoprotein fatty acids in humans: their effect on low-density lipoprotein-fibroblast interactionsM F Baudet, O Esteva, M Lasserre, et al.
La Nouvelle Presse Medicale|March 10, 1979
[Type V hyperlipemia. 54 cases (author's transl)]M Schlesinger, B Jacotot, V Beaumont, et al.
Coeur Et Medecine Interne|October 1, 1972
[Pulmonary emboli caused by hormonal treatment. (Apropos of 2 cases)]F Jan, P Sébastien, B Jacotot, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
La Revue De Medecine Interne|January 1, 1996
[Homocysteine: relations to ischemic cardiovascular diseases]A Piolot, F Nadler, N Parez, et al.
Biochimica Et Biophysica Acta|August 28, 1990
Fluidity changes and chemical composition of lipoproteins in type IIa hyperlipoproteinemiaC Dachet, C Motta, D Neufcour, et al.
Comptes Rendus Hebdomadaires Des Seances De L'Academie Des Sciences. Serie D: Sciences Naturelles|May 12, 1975
[The composition of dietary lipids and the blood coagulation time in the rat]B Jacotot, H Rosenstein, M Claire, et al.
The American Journal of Medicine|June 6, 1994
Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study GroupJ D Banga, B Jacotot, P Pfister, et al.
British Journal of Clinical Pharmacology|September 1, 1994
Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study GroupB Jacotot, J D Banga, P Pfister, et al.
Pathologie-Biologie|June 29, 2001
Effect of an alpha-blocker (Nicergoline) and of a beta-blocker (Acebutolol) on the in vitro biosynthesis of vascular extracellular matrixM Moczar, A M Robert, B Jacotot, et al.
Atherosclerosis|October 1, 1986
Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemiaM F Baudet, O Esteva, C Dachet, et al.
Clinical Physiology and Biochemistry|January 1, 1986
Dietary modifications of low-density lipoprotein fatty acids in humans: their effect on low-density lipoprotein-fibroblast interactionsM F Baudet, O Esteva, M Lasserre, et al.
La Nouvelle Presse Medicale|March 10, 1979
[Type V hyperlipemia. 54 cases (author's transl)]M Schlesinger, B Jacotot, V Beaumont, et al.
Coeur Et Medecine Interne|October 1, 1972
[Pulmonary emboli caused by hormonal treatment. (Apropos of 2 cases)]F Jan, P Sébastien, B Jacotot, et al.
Pageof 15